_id
691b08613c536f8df2318966
Ticker
AFME.PA
Name
Affluent Medical SAS
Exchange
PA
Address
320, avenue ArchimEde, Aix-en-Provence, France, 13100
Country
France
Sector
Healthcare
Industry
Medical Devices
Currency
EUR
Website
https://www.affluentmedical.com
Description
Affluent Medical SA, a medical technology company, develops and markets minimally invasive minimally invasive medical devices in the field of urology and structural heart in France. It offers Artus, an implantable electro-mechanical artificial sphincter that targets moderate to severe urinary incontinence; and Kalios and Epygon implants for the treatment of mitral insufficiency, as well as Kardiozis technology for treating abdominal aortic aneurysm. The company was founded in 2011 and is headquartered in Aix-en-Provence, France.
Last Close
1.745
Volume
9415
Current Price
1.87
Change
-0.5730659025787971
Last Updated
2025-12-30T12:32:51.723Z
Image
https://logo.clearbit.com/www.affluentmedical.com
Ipo Date
-
Market Cap
68575128
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4.33
Strong Buy
1
Buy
2
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-06-30
Revenue
577000
Cost Of Revenue
1719000
Gross Profit
-1142000
Operating Expenses
2616000
Operating Income
-9727000
Interest Expense
700000
Pretax Income
-9979000
Net Income
-9372000
Eps
-0.23818100465317038
Dividends Per Share
-
Shares Outstanding
39295519
Income Tax Expense
-607000
EBITDA
-8106000
Operating Margin
-1685.7885615251298
Total Other Income Expense Net
-252000
Cash
5338000
Short Term Investments
15000
Receivables
4182000
Inventories
-
Total Current Assets
12077000
Property Plant Equipment
1151000
Total Assets
59837000
Payables
5096000
Short Term Debt
2320000
Long Term Debt
20696000
Total Liabilities
38727000
Equity
21110000
Bs_currency_symbol
EUR
Depreciation
1173000
Change In Working Capital
821000
Cash From Operations
-6740000
Capital Expenditures
105000
Cash From Investing
5213000
Cash From Financing
5638000
Net Change In Cash
4109000
Cf_currency_symbol
-
PE
-
PB
3.485607892941734
ROE
-44.39602084320227
ROA
-15.662549927302505
FCF
-6845000
Fcf Percent
-11.8630849220104
Piotroski FScore
1
Health Score
20
Deep Value Investing Score
1.5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
1.5
Growth Investing Score
1
Momentum Investing Score
3.5
Net Net Investing Score
1
Quality Investing Score
1.5
Value Investing Score
2.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
577000
Quarters > 0 > income Statement > cost Of Revenue
1719000
Quarters > 0 > income Statement > gross Profit
-1142000
Quarters > 0 > income Statement > operating Expenses
2616000
Quarters > 0 > income Statement > operating Income
-9727000
Quarters > 0 > income Statement > interest Expense
700000
Quarters > 0 > income Statement > pretax Income
-9979000
Quarters > 0 > income Statement > net Income
-9372000
Quarters > 0 > income Statement > eps
-0.23818100465317038
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
39348226
Quarters > 0 > income Statement > income Tax Expense
-607000
Quarters > 0 > income Statement > EBITDA
-8106000
Quarters > 0 > income Statement > operating Margin
-1685.7885615251298
Quarters > 0 > income Statement > total Other Income Expense Net
-252000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
5338000
Quarters > 0 > balance Sheet > short Term Investments
15000
Quarters > 0 > balance Sheet > receivables
4182000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
12077000
Quarters > 0 > balance Sheet > property Plant Equipment
1151000
Quarters > 0 > balance Sheet > total Assets
59837000
Quarters > 0 > balance Sheet > payables
5096000
Quarters > 0 > balance Sheet > short Term Debt
2320000
Quarters > 0 > balance Sheet > long Term Debt
20696000
Quarters > 0 > balance Sheet > total Liabilities
38727000
Quarters > 0 > balance Sheet > equity
21110000
Quarters > 0 > balance Sheet > currency_symbol
EUR
Quarters > 0 > cash Flow > net Income
-9372000
Quarters > 0 > cash Flow > depreciation
1173000
Quarters > 0 > cash Flow > change In Working Capital
821000
Quarters > 0 > cash Flow > cash From Operations
-6740000
Quarters > 0 > cash Flow > capital Expenditures
105000
Quarters > 0 > cash Flow > cash From Investing
5213000
Quarters > 0 > cash Flow > cash From Financing
5638000
Quarters > 0 > cash Flow > net Change In Cash
4109000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.23818100465317038
Quarters > 0 > ratios > PB
3.485607892941734
Quarters > 0 > ratios > ROE
-44.39602084320227
Quarters > 0 > ratios > ROA
-15.662549927302505
Quarters > 0 > ratios > FCF
-6845000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-11.8630849220104
Quarters > 0 > health Score
20
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
4118000
Quarters > 1 > income Statement > cost Of Revenue
12289000
Quarters > 1 > income Statement > gross Profit
-3303000
Quarters > 1 > income Statement > operating Expenses
-1918000
Quarters > 1 > income Statement > operating Income
-6132000
Quarters > 1 > income Statement > interest Expense
497000
Quarters > 1 > income Statement > pretax Income
-5987000
Quarters > 1 > income Statement > net Income
-5371000
Quarters > 1 > income Statement > eps
-0.1365069951638502
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
39345969
Quarters > 1 > income Statement > income Tax Expense
-616000
Quarters > 1 > income Statement > EBITDA
-5177000
Quarters > 1 > income Statement > operating Margin
-148.9072365225838
Quarters > 1 > income Statement > total Other Income Expense Net
145000
Quarters > 1 > income Statement > currency_symbol
EUR
Quarters > 1 > balance Sheet > cash
1229000
Quarters > 1 > balance Sheet > short Term Investments
5393000
Quarters > 1 > balance Sheet > receivables
3449000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
12155000
Quarters > 1 > balance Sheet > property Plant Equipment
1248000
Quarters > 1 > balance Sheet > total Assets
60858000
Quarters > 1 > balance Sheet > payables
4730000
Quarters > 1 > balance Sheet > short Term Debt
1741000
Quarters > 1 > balance Sheet > long Term Debt
14080000
Quarters > 1 > balance Sheet > total Liabilities
30587000
Quarters > 1 > balance Sheet > equity
30271000
Quarters > 1 > balance Sheet > currency_symbol
EUR
Quarters > 1 > cash Flow > net Income
-5371000
Quarters > 1 > cash Flow > depreciation
1196000
Quarters > 1 > cash Flow > change In Working Capital
-3271000
Quarters > 1 > cash Flow > cash From Operations
-7622000
Quarters > 1 > cash Flow > capital Expenditures
64000
Quarters > 1 > cash Flow > cash From Investing
-416000
Quarters > 1 > cash Flow > cash From Financing
8346999
Quarters > 1 > cash Flow > net Change In Cash
314000
Quarters > 1 > cash Flow > currency_symbol
EUR
Quarters > 1 > ratios > PE
-0.1365069951638502
Quarters > 1 > ratios > PB
2.430608900597932
Quarters > 1 > ratios > ROE
-17.743054408509796
Quarters > 1 > ratios > ROA
-8.825462552170627
Quarters > 1 > ratios > FCF
-7686000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-1.8664400194269062
Quarters > 1 > health Score
24
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
661000
Quarters > 2 > income Statement > cost Of Revenue
1101000
Quarters > 2 > income Statement > gross Profit
-440000
Quarters > 2 > income Statement > operating Expenses
8367000
Quarters > 2 > income Statement > operating Income
-9557000
Quarters > 2 > income Statement > interest Expense
739000
Quarters > 2 > income Statement > pretax Income
-10094000
Quarters > 2 > income Statement > net Income
-9368000
Quarters > 2 > income Statement > eps
-0.2857152094001524
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
32787894
Quarters > 2 > income Statement > income Tax Expense
-726000
Quarters > 2 > income Statement > EBITDA
-8266000
Quarters > 2 > income Statement > operating Margin
-1445.839636913767
Quarters > 2 > income Statement > total Other Income Expense Net
-537000
Quarters > 2 > income Statement > currency_symbol
EUR
Quarters > 2 > balance Sheet > cash
915000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
4451000
Quarters > 2 > balance Sheet > inventories
1111000
Quarters > 2 > balance Sheet > total Current Assets
6476000
Quarters > 2 > balance Sheet > property Plant Equipment
1422000
Quarters > 2 > balance Sheet > total Assets
56225000
Quarters > 2 > balance Sheet > payables
4046000
Quarters > 2 > balance Sheet > short Term Debt
3242000
Quarters > 2 > balance Sheet > long Term Debt
13627000
Quarters > 2 > balance Sheet > total Liabilities
30201000
Quarters > 2 > balance Sheet > equity
26024000
Quarters > 2 > balance Sheet > currency_symbol
EUR
Quarters > 2 > cash Flow > net Income
-9368000
Quarters > 2 > cash Flow > depreciation
1202000
Quarters > 2 > cash Flow > change In Working Capital
2160000
Quarters > 2 > cash Flow > cash From Operations
-3702000
Quarters > 2 > cash Flow > capital Expenditures
64000
Quarters > 2 > cash Flow > cash From Investing
-64000
Quarters > 2 > cash Flow > cash From Financing
3023000
Quarters > 2 > cash Flow > net Change In Cash
-743000
Quarters > 2 > cash Flow > currency_symbol
EUR
Quarters > 2 > ratios > PE
-0.2857152094001524
Quarters > 2 > ratios > PB
2.356031424070089
Quarters > 2 > ratios > ROE
-35.99754073163234
Quarters > 2 > ratios > ROA
-16.66162738995109
Quarters > 2 > ratios > FCF
-3766000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-5.697428139183056
Quarters > 2 > health Score
25
Quarters > 3 > quarter
2024-03-31
Quarters > 3 > income Statement > revenue
330500
Quarters > 3 > income Statement > cost Of Revenue
459000
Quarters > 3 > income Statement > gross Profit
-128500
Quarters > 3 > income Statement > operating Expenses
4275000
Quarters > 3 > income Statement > operating Income
-4403500
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-4722500
Quarters > 3 > income Statement > net Income
-4684000
Quarters > 3 > income Statement > eps
-0.14702439757506422
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
31858658
Quarters > 3 > income Statement > income Tax Expense
38500
Quarters > 3 > income Statement > EBITDA
-3802500
Quarters > 3 > income Statement > operating Margin
-1332.375189107413
Quarters > 3 > income Statement > total Other Income Expense Net
-319000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
-
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
1658000
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
-
Quarters > 3 > balance Sheet > payables
-
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
-31525000
Quarters > 3 > balance Sheet > equity
31525000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-4684000
Quarters > 3 > cash Flow > depreciation
601000
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-1851000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
1511500
Quarters > 3 > cash Flow > net Change In Cash
-371500
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.14702439757506422
Quarters > 3 > ratios > PB
1.889791925773196
Quarters > 3 > ratios > ROE
-14.858049167327517
Quarters > 3 > ratios > ROA
-
Quarters > 3 > ratios > FCF
-1851000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-5.6006051437216335
Quarters > 3 > health Score
40
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
4118000
Annuals > 0 > income Statement > cost Of Revenue
13390000
Annuals > 0 > income Statement > gross Profit
-9272000
Annuals > 0 > income Statement > operating Expenses
6449000
Annuals > 0 > income Statement > operating Income
-15689000
Annuals > 0 > income Statement > interest Expense
242000
Annuals > 0 > income Statement > pretax Income
-16081000
Annuals > 0 > income Statement > net Income
-14739000
Annuals > 0 > income Statement > eps
-0.3746000003202361
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
39345969
Annuals > 0 > income Statement > income Tax Expense
-1342000
Annuals > 0 > income Statement > EBITDA
-13443000
Annuals > 0 > income Statement > operating Margin
-380.98591549295776
Annuals > 0 > income Statement > total Other Income Expense Net
-392000
Annuals > 0 > income Statement > currency_symbol
EUR
Annuals > 0 > balance Sheet > cash
1229000
Annuals > 0 > balance Sheet > short Term Investments
5393000
Annuals > 0 > balance Sheet > receivables
3449000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
12155000
Annuals > 0 > balance Sheet > property Plant Equipment
1248000
Annuals > 0 > balance Sheet > total Assets
60858000
Annuals > 0 > balance Sheet > payables
4730000
Annuals > 0 > balance Sheet > short Term Debt
1741000
Annuals > 0 > balance Sheet > long Term Debt
14080000
Annuals > 0 > balance Sheet > total Liabilities
30587000
Annuals > 0 > balance Sheet > equity
30271000
Annuals > 0 > balance Sheet > currency_symbol
EUR
Annuals > 0 > cash Flow > net Income
-14739000
Annuals > 0 > cash Flow > depreciation
2410000
Annuals > 0 > cash Flow > change In Working Capital
205000
Annuals > 0 > cash Flow > cash From Operations
-11324000
Annuals > 0 > cash Flow > capital Expenditures
147000
Annuals > 0 > cash Flow > cash From Investing
-480000
Annuals > 0 > cash Flow > cash From Financing
11370000
Annuals > 0 > cash Flow > net Change In Cash
-434000
Annuals > 0 > cash Flow > currency_symbol
EUR
Annuals > 0 > ratios > PE
-0.3746000003202361
Annuals > 0 > ratios > PB
2.2551371350467444
Annuals > 0 > ratios > ROE
-48.69016550493872
Annuals > 0 > ratios > ROA
-24.218672976436952
Annuals > 0 > ratios > FCF
-11471000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-2.7855755220981058
Annuals > 0 > health Score
24
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
1224000
Annuals > 1 > income Statement > cost Of Revenue
2424000
Annuals > 1 > income Statement > gross Profit
-1200000
Annuals > 1 > income Statement > operating Expenses
11866000
Annuals > 1 > income Statement > operating Income
-13066000
Annuals > 1 > income Statement > interest Expense
393000
Annuals > 1 > income Statement > pretax Income
-17010000
Annuals > 1 > income Statement > net Income
-15653000
Annuals > 1 > income Statement > eps
-0.5380580603593003
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
29091656
Annuals > 1 > income Statement > income Tax Expense
-1357000
Annuals > 1 > income Statement > EBITDA
-13343000
Annuals > 1 > income Statement > operating Margin
-1067.483660130719
Annuals > 1 > income Statement > total Other Income Expense Net
-3944000
Annuals > 1 > income Statement > currency_symbol
EUR
Annuals > 1 > balance Sheet > cash
1658000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
3401000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
5793000
Annuals > 1 > balance Sheet > property Plant Equipment
1596000
Annuals > 1 > balance Sheet > total Assets
56623000
Annuals > 1 > balance Sheet > payables
3373000
Annuals > 1 > balance Sheet > short Term Debt
2077000
Annuals > 1 > balance Sheet > long Term Debt
14411000
Annuals > 1 > balance Sheet > total Liabilities
25151000
Annuals > 1 > balance Sheet > equity
31472000
Annuals > 1 > balance Sheet > currency_symbol
EUR
Annuals > 1 > cash Flow > net Income
-15653000
Annuals > 1 > cash Flow > depreciation
2413000
Annuals > 1 > cash Flow > change In Working Capital
235000
Annuals > 1 > cash Flow > cash From Operations
-12054000
Annuals > 1 > cash Flow > capital Expenditures
184000
Annuals > 1 > cash Flow > cash From Investing
-184000
Annuals > 1 > cash Flow > cash From Financing
11316000
Annuals > 1 > cash Flow > net Change In Cash
-922000
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
-0.5380580603593003
Annuals > 1 > ratios > PB
1.603775519827148
Annuals > 1 > ratios > ROE
-49.736273512963905
Annuals > 1 > ratios > ROA
-27.644243505289367
Annuals > 1 > ratios > FCF
-12238000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-9.998366013071895
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
1339000
Annuals > 2 > income Statement > cost Of Revenue
2443000
Annuals > 2 > income Statement > gross Profit
-1104000
Annuals > 2 > income Statement > operating Expenses
13200000
Annuals > 2 > income Statement > operating Income
-11883000
Annuals > 2 > income Statement > interest Expense
1080000
Annuals > 2 > income Statement > pretax Income
-15400000
Annuals > 2 > income Statement > net Income
-15227000
Annuals > 2 > income Statement > eps
-0.8062339724133176
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
18886577
Annuals > 2 > income Statement > income Tax Expense
-173000
Annuals > 2 > income Statement > EBITDA
-13214000
Annuals > 2 > income Statement > operating Margin
-887.4533233756536
Annuals > 2 > income Statement > total Other Income Expense Net
-3517000
Annuals > 2 > income Statement > currency_symbol
EUR
Annuals > 2 > balance Sheet > cash
2580000
Annuals > 2 > balance Sheet > short Term Investments
-35000
Annuals > 2 > balance Sheet > receivables
4048000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
7181000
Annuals > 2 > balance Sheet > property Plant Equipment
1755000
Annuals > 2 > balance Sheet > total Assets
60020000
Annuals > 2 > balance Sheet > payables
3020000
Annuals > 2 > balance Sheet > short Term Debt
2062000
Annuals > 2 > balance Sheet > long Term Debt
14934000
Annuals > 2 > balance Sheet > total Liabilities
26188000
Annuals > 2 > balance Sheet > equity
33832000
Annuals > 2 > balance Sheet > currency_symbol
EUR
Annuals > 2 > cash Flow > net Income
-15227000
Annuals > 2 > cash Flow > depreciation
2348000
Annuals > 2 > cash Flow > change In Working Capital
717000
Annuals > 2 > cash Flow > cash From Operations
-11081000
Annuals > 2 > cash Flow > capital Expenditures
146000
Annuals > 2 > cash Flow > cash From Investing
-146000
Annuals > 2 > cash Flow > cash From Financing
2401000
Annuals > 2 > cash Flow > net Change In Cash
-8826000
Annuals > 2 > cash Flow > currency_symbol
EUR
Annuals > 2 > ratios > PE
-0.8062339724133176
Annuals > 2 > ratios > PB
0.9685567242551432
Annuals > 2 > ratios > ROE
-45.00768503192244
Annuals > 2 > ratios > ROA
-25.369876707764078
Annuals > 2 > ratios > FCF
-11227000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-8.384615384615385
Annuals > 2 > health Score
29
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
1451000
Annuals > 3 > income Statement > cost Of Revenue
2741000
Annuals > 3 > income Statement > gross Profit
-1290000
Annuals > 3 > income Statement > operating Expenses
11254000
Annuals > 3 > income Statement > operating Income
-13233000
Annuals > 3 > income Statement > interest Expense
3055000
Annuals > 3 > income Statement > pretax Income
-15257000
Annuals > 3 > income Statement > net Income
-14820000
Annuals > 3 > income Statement > eps
-0.797120898283178
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
18591910
Annuals > 3 > income Statement > income Tax Expense
-437000
Annuals > 3 > income Statement > EBITDA
-10888000
Annuals > 3 > income Statement > operating Margin
-911.9917298414887
Annuals > 3 > income Statement > total Other Income Expense Net
-2010000
Annuals > 3 > income Statement > currency_symbol
EUR
Annuals > 3 > balance Sheet > cash
11410000
Annuals > 3 > balance Sheet > short Term Investments
-117000
Annuals > 3 > balance Sheet > receivables
2893000
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
14675000
Annuals > 3 > balance Sheet > property Plant Equipment
2006000
Annuals > 3 > balance Sheet > total Assets
70035000
Annuals > 3 > balance Sheet > payables
1793000
Annuals > 3 > balance Sheet > short Term Debt
2753000
Annuals > 3 > balance Sheet > long Term Debt
16085000
Annuals > 3 > balance Sheet > total Liabilities
26500000
Annuals > 3 > balance Sheet > equity
43535000
Annuals > 3 > balance Sheet > currency_symbol
EUR
Annuals > 3 > cash Flow > net Income
-14820000
Annuals > 3 > cash Flow > depreciation
2332000
Annuals > 3 > cash Flow > change In Working Capital
-1136000
Annuals > 3 > cash Flow > cash From Operations
-12364000
Annuals > 3 > cash Flow > capital Expenditures
334000
Annuals > 3 > cash Flow > cash From Investing
-160000
Annuals > 3 > cash Flow > cash From Financing
18281000
Annuals > 3 > cash Flow > net Change In Cash
5757000
Annuals > 3 > cash Flow > currency_symbol
EUR
Annuals > 3 > ratios > PE
-0.797120898283178
Annuals > 3 > ratios > PB
0.7409432376248996
Annuals > 3 > ratios > ROE
-34.041575743654526
Annuals > 3 > ratios > ROA
-21.160848147354894
Annuals > 3 > ratios > FCF
-12698000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-8.751206064782908
Annuals > 3 > health Score
29
Valuation > metrics > PE
-0.23818100465317038
Valuation > metrics > PB
3.485607892941734
Valuation > final Score
45.143921070582664
Valuation > verdict
16.2% Overvalued
Profitability > metrics > ROE
-44.39602084320227
Profitability > metrics > ROA
-77.60205349010516
Profitability > metrics > Net Margin
-16.24263431542461
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.8345333964945523
Risk > metrics > Interest Coverage
-13.895714285714286
Risk > final Score
-26
Risk > verdict
High
Liquidity > metrics > Current Ratio
1.6285059331175835
Liquidity > metrics > Quick Ratio
1.6285059331175835
Liquidity > final Score
91
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
80
Prev Valuations > 2
80
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-19
Prev Risks > 1
-22
Prev Risks > 2
41
Prev Liquidities > 0
97
Prev Liquidities > 1
47
Prev Liquidities > 2
50
Updated At
2026-01-20T23:08:27.416Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-12-03
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-09-25
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.24
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.24
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-02
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.14
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.14
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-09-30
Earnings History > 3 > report Date
2024-11-27
Earnings History > 3 > date
2024-09-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
0
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-06-30
Earnings History > 4 > report Date
2024-09-26
Earnings History > 4 > date
2024-06-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
0
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-03-31
Earnings History > 5 > report Date
2024-04-25
Earnings History > 5 > date
2024-03-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
0
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2023-03-31
Earnings History > 6 > report Date
2023-05-02
Earnings History > 6 > date
2023-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
EUR
Earnings History > 6 > eps Actual
-0.37
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2022-06-30
Earnings History > 7 > report Date
2022-09-28
Earnings History > 7 > date
2022-06-30
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
EUR
Earnings History > 7 > eps Actual
-0.44
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
-0.44
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2022-03-31
Earnings History > 8 > report Date
2022-04-30
Earnings History > 8 > date
2022-03-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
EUR
Earnings History > 8 > eps Actual
-0.39
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
-0.39
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2021-06-30
Earnings History > 9 > report Date
2021-09-22
Earnings History > 9 > date
2021-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
EUR
Earnings History > 9 > eps Actual
-0.39
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.39
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2021-03-31
Earnings History > 10 > report Date
2021-04-14
Earnings History > 10 > date
2021-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
EUR
Earnings History > 10 > eps Actual
-0.4
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.4
Earnings History > 10 > surprise Percent
-
Affluent Medical SA, a medical technology company, develops and markets minimally invasive minimally invasive medical devices in the field of urology and structural heart in France. It offers Artus, an implantable electro-mechanical artificial sphincter that targets moderate to severe urinary incontinence; and Kalios and Epygon implants for the treatment of mitral insufficiency, as well as Kardiozis technology for treating abdominal aortic aneurysm. The company was founded in 2011 and is headquartered in Aix-en-Provence, France.
Stock Price
€0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AAFME provides an action plan for European tokenization ledgerinsights.com
Read more →(Last Updated 2025-06-30)
Rating:
BUY
$
Analyst Picks
Strong Buy
1
Buy
2
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Affluent Medical SAS
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
0
EPS Estimate
0
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
€ 0
Cost Of Revenue
€ 0
Gross Profit
€ 0
Operating Expenses
€ 0
Operating Income
€ 0
Interest Expense
€ 0
Pretax Income
€ 0
Net Income
€ 0
Income Tax Expense
€ 0
EBITDA
€ 0
Total Other Income Expense Net
€ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
€ 0
Short Term Investments
€ 0
Receivables
€ 0
Inventories
€ 0
Total Current Assets
€ 0
Property Plant Equipment
€ 0
Total Assets
€ 0
Payables
€ 0
Short Term Debt
€ 0
Long Term Debt
€ 0
Total Liabilities
€ 0
Equity
€ 0
(Last Updated 2025-06-30)
Net Income
€ 0
Depreciation
€ 0
Change In Working Capital
€ 0
Cash From Operations
€ 0
Capital Expenditures
€ 0
Cash From Investing
€ 0
Cash From Financing
€ 0
Net Change In Cash
€ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.